The problem
Minimally invasive surgery offers significant benefits over conventional surgery. Smaller incisions lead to faster healing times and improved patient outcomes. However, these intricate procedures can be challenging to perform. Up to one in six surgeries still result in complications, many of which could be prevented by using better surgical planning tools.
The solution
Innersight’s 3D modelling technology can be used by surgeons to improve operative planning. It uses medical scans to create interactive, 3D models of a patient’s anatomy. Surgeons can then refine these models, using interactive artificial intelligence tools, to plan surgeries and visualise potential risks.
The technology uses deep learning algorithms to create accurate models that can be viewed on mobile devices, used in virtual reality or 3D printed. Innersight’s solutions are web-based, allowing surgeons to build and view models from any computer with an internet connection without installing specialised software.
Their retrospective clinical study has shown that the technology has helped surgeons adapt their approach in up to one in five cases. This leads to better informed decisions about, for example, which vessels to clamp or the right area for tissue incision. By reducing the risk of complications, the technology will help patients to have shorter hospital stays and save healthcare providers money.
Dr Eoin Hyde, CEO, draws on significant experience in computational physiology and the development of medical devices, as he leads Innersight towards making its technology widely available.
From abdominal and thoracic soft-tissue operations to orthopaedics and cardiac surgeries, Innersight is expanding its products to capture a share of the global minimally invasive surgery market, currently valued at $40 billion.
Traction
- 2019: Ethical approval granted for a prospective study hosted at the Royal Free Hospital, London. Innersight included as one of 10 SMEs to partner with the new London Medical Imaging and Artificial Intelligence Centre for Value-Based Healthcare
- 2017: Awarded funding from the MedCity Collaborate to Innovate and National Institute for Health Research Invention for Innovation Connect programmes
- 2016: Won the London Business School Healthtech Challenge
- 2015: Awarded Innovate UK Smart award for proof-of-concept
Dr Hyde was awarded a 2018 Enterprise Fellowship to support him as he leads Innersight in bringing its solutions to market.
